Adults with type 2 diabetes will have a new alternative to daily insulin injections now that the U.S. Food and Drug Administration (FDA) approved a new once-a-week insulin injection.

Patients with type 2 diabetes who stop taking GLP-1 drugs such as semaglutide or tirzepatide face a 22% higher risk of heart ...

An Australian-first study by the Registry of Senior Australians (ROSA) investigating the use of blood sugar-lowering medications among residents with diabetes in aged care homes nationwide, has ...

Diabetes is the most common cause of chronic kidney disease (CKD). Around 33 percent of adults with diabetes may also have CKD. When diabetes causes CKD, its sometimes called diabetic kidney disease.

Diabetes affects more than 1 in 10—or more than 38 million—Americans. People with diabetes who keep their blood sugar levels in the near-normal range generally have a much lower risk of developing ...

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope ...

Discover how controlling blood sugar prevents heart attacks, heart failure, and vessel damage. Expert insights from leading ...

A new study led by UCLA Health found that a large percentage of disadvantaged patients are not taking their diabetes ...

Recently in Shenzhen, China, the Center for Integrative Medicine for Chronic Diseases and the Center for Natural Diabetes Therapy at Shenzhen Hengsheng Hospital—a subsidiary of Fosun Health—announced ...